The Multiple Cancer Screening Test is an advanced blood-based screening test designed to detect circulating tumour cells (CTCs) in the bloodstream. These cells may be released into the blood during the very early stages of cancer development, sometimes before symptoms appear. This test supports a proactive approach to health by offering early insight into potential cancer-related signals, helping guide timely clinical review and appropriate next steps. It may be suitable for individuals seeking preventive health screening, those with a family history of cancer, or anyone wishing to include cancer screening as part of a comprehensive or longevity-focused health assessment. This test is intended for screening purposes only and does not provide a cancer diagnosis.
Included
- GP-led review
- Personalised doctor’s comments
- Clear guidance on next steps
- UK-accredited laboratory analysis
What It Assesses
- Circulating Tumour Cells (CTCs)
Sample Collection Options
- A clinician collects a venous blood sample during your appointment.
Turnaround
Typically, 7–10 working days after the laboratory receives your sample.
Price
£495.00
FAQs
How can this scan help me?
This scan can: Support early insight into potential cancer risk Detect circulating tumour cells before symptoms develop Provide reassurance when results are negative Support proactive and preventive health planning Guide appropriate follow-up investigations if required It is designed for early screening, not diagnostic confirmation.
How is the sample taken?
A clinician collects a venous blood sample during your appointment.
How long does the scan take?
Typically, 7–10 working days after the laboratory receives your sample.
Will I receive help interpreting my results?
Yes — every scan includes: A clinical imaging report Expert interpretation Clear recommendations on next steps, if required
IMPORTANT INFORMATION
This Multiple Cancer Screening Test is not a diagnostic test and should not be used as the sole method for diagnosing cancer. If circulating tumour cells are detected, your clinician may recommend further investigations or specialist referral.
